UCB receives EC approval for Bimzelx in hidradenitis suppurativa
Dermatology In Practice
by
2h ago
The therapy is already approved in the EU to treat plaque psoriasis, psoriatic arthritis and axial spondyloarthritis ..read more
Visit website
LEO reports positive late-stage results for Enstilar in adults with stable plaque psoriasis
Dermatology In Practice
by
2h ago
The aerosol spray foam was superior to LEO’s Daivobet ointment in the trial’s primary endpoint ..read more
Visit website
UK study uncovers two genes offering potential drug targets against skin cancer
Dermatology In Practice
by
1w ago
Scientists believe that both genes could be targeted to prevent melanoma from metastasising ..read more
Visit website
Dermavant shares promising late-stage results for Vtama cream in atopic dermatitis
Dermatology In Practice
by
3w ago
Vtama cream demonstrated statistically significant efficacy across a range of skin tones ..read more
Visit website
UCB shares positive late-stage results for Bimzelx in plaque psoriasis
Dermatology In Practice
by
3w ago
Bimzelx works to inhibit two cytokines that drive inflammatory processes ..read more
Visit website
Eli Lilly reports positive phase 3 results for lebrikizumab in atopic dermatitis
Dermatology In Practice
by
1M ago
The medicine was evaluated in 50 patients with moderate-to-severe cases of the condition and darker skin tones ..read more
Visit website
Almirall gains rights to Eloxx Pharmaceuticals’ rare dermatological disease therapy in $470m deal
Dermatology In Practice
by
1M ago
Almirall will gain global rights to develop and commercialise the asset in rare dermatological and other diseases associated with nonsense mutations ..read more
Visit website
UK survey highlights impact of vitiligo on patients’ mental health
Dermatology In Practice
by
1M ago
The Vitiligo Society has called for greater awareness surrounding the condition ..read more
Visit website
Novartis receives SMC approval for Consentyx in hidradenitis suppurativa
Dermatology In Practice
by
1M ago
The long-term skin condition affects approximately 2% of the Scottish population ..read more
Visit website
Almirall acquires rights to Novo’s IL-21 blocker for dermatological disease indications
Dermatology In Practice
by
1M ago
The candidate has been developed up to mid-stage in non-dermatological indications ..read more
Visit website

Follow Dermatology In Practice on FeedSpot

Continue with Google
Continue with Apple
OR